
MiNK Therapeutics (INKT)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy MiNK Therapeutics (INKT) Stock
Start investing in MiNK Therapeutics (INKT)
About MiNK Therapeutics (INKT)
Market cap | $29.44M |
Today's volume | 1.26K |
Revenue (TTM) | — |
Avg. daily volume | 7.92K |
EBITDA (TTM) | -$9.14M |
Open | $7.36 |
Price / earnings ratio | -2.95x |
Today's range | $7.36 - $7.36 |
Debt / equity | — |
52 week range | $4.56 - $13.79 |
5 year debt / equity | -21.3x |
Beta (LTM) | 0.41x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 0.3x |
Ex-dividend date | — |
Next earnings | Aug 12, 2025 |
Dividend payable date | — |
MiNK Therapeutics Stock Rating
MiNK Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy INKT stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in INKT stock
Navigate to the Explore page. Then, type INKT into the search bar. When you see INKT stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased INKT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
MiNK Therapeutics Stock Earnings
The value each INKT share was expected to gain vs. the value that each INKT share actually gained.
MiNK Therapeutics (INKT) reported Q1 2025 earnings per share (EPS) of -$0.70, missing estimates of -$0.61 by 14.75%. In the same quarter last year, MiNK Therapeutics's earnings per share (EPS) was -$0.11. MiNK Therapeutics is expected to release next earnings on 08/12/2025, with an earnings per share (EPS) estimate of -$0.46.